Oncology Views & Analysis

Views & Analysis

Oncology

Cancer Research UK teams up with Sosei Heptares

Anatomy of a partnership: Cancer Research UK teams up with S...

Cancer Research UK is working with global biopharma Sosei Heptares on a treatment they hope will bring immunotherapy benefits to new cancer types.

Digital

AI tissue analysis enables rapid discovery of drug candidate...

AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential to use tissue samples to create precision medicine for specific patient gr

Oncology

The challenges and opportunities for kidney cancer care reco...

Kidney cancer care is rapidly approaching a tipping point in the UK.

Oncology

Realising the promise of genomic testing across oncology

Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world.

Oncology

Oncology market dominance: As easy as ADC?

Antibody-drug conjugates are coming back to the fore, with talks of multi-billion dollar buyouts and a rapidly growing number of approvals.

Oncology

Diversity by design: the importance of DE&I in oncology tria...

“First, do no harm”; is an ethical axiom at the heart of medical research; physicians worldwide pledge to uphold the oath to serve patients.

Anatomy of a partnership: Cancer Research UK teams up with S...

AI tissue analysis enables rapid discovery of drug candidate...

The challenges and opportunities for kidney cancer care reco...

Realising the promise of genomic testing across oncology

Oncology market dominance: As easy as ADC?

Diversity by design: the importance of DE&I in oncology tria...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Views & Analysis

Editor's Picks